← Every firm

PD-Rx Pharmaceuticals, Inc. FDA Recalls

9 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product
DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDCClass IIDec 4, 2024CGMP Deviations: the presence of a Nitrosamine Drug Substanc
Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated OklahoClass IIApr 6, 2023CGMP deviations.
Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals IncorporatedClass IIApr 6, 2023CGMP deviations.
Simvastatin USP 20 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Class IIApr 6, 2023CGMP deviations.
Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Class IIApr 6, 2023CGMP deviations.
Montelukast Sodium USP, 10 mg, 30 count-bottles, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx PhaClass IIApr 6, 2023CGMP deviations.
Losartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc.Class IIJun 6, 2022CGMP Deviations- AZIDO Impurity levels observed to be above
Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc.Class IIJun 6, 2022CGMP Deviations- AZIDO Impurity levels observed to be above
Losartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed and Packaged By: PD-Rx Pharmaceuticals, InClass IIJun 6, 2022CGMP Deviations- AZIDO Impurity levels observed to be above

Related datasets